Literature DB >> 22314685

Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.

Edward Rockenstein1, Kiren Ubhi, Chandra Inglis, Michael Mante, Christina Patrick, Anthony Adame, Eliezer Masliah.   

Abstract

Multiple system atrophy is a sporadic, progressive, neurodegenerative disease characterized by an oligodendroglial accumulation of alpha-synuclein (α-syn). The mechanisms underlying the oligodendroglial accumulation of α-syn in the brains of patients with multiple system atrophy have attracted a great deal of interest, given the primarily neuronal role reported for this protein. We examined the interactions between neuronal and oligodendroglial α-syn in the progeny of crosses between parental transgenic (tg) mouse lines that express α-syn either under the oligodendroglial-specific myelin-basic protein promoter (MBP1-hα-syn tg) or under the neuronal platelet-derived growth factor promoter (PDGF-hα-syn tg). Our results demonstrate that progeny from the cross [hα-syn double (dbl) tg mice] displayed a robust redistribution of α-syn accumulation, with a relocalization from a neuronal or a mixed neuronal/oligodendroglial α-syn expression to a more oligodendroglial pattern in both the neocortex and the basal ganglia that closely resembled the parental MBP-hα-syn tg line. The hα-syn dbl tg mice also displayed motor deficits, concomitant with reduced levels of tyrosine hydroxylase and augmented neuropathological alterations in the basal ganglia. These results suggest that the central nervous system milieu in the hα-syn dbl tg mice favors an oligodendroglial accumulation of α-syn. This model represents an important tool to examine the interactions between neuronal and oligodendrocytic α-syn in diseases such as multiple system atrophy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314685      PMCID: PMC3289254          DOI: 10.1097/WNR.0b013e3283509842

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  23 in total

1.  Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion.

Authors:  K Matsuura; H Kabuto; H Makino; N Ogawa
Journal:  J Neurosci Methods       Date:  1997-04-25       Impact factor: 2.390

Review 2.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

3.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

4.  Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

Authors:  Clifford W Shults; Edward Rockenstein; Leslie Crews; Anthony Adame; Michael Mante; Gabriel Larrea; Makoto Hashimoto; David Song; Takeshi Iwatsubo; Kyoko Tsuboi; Eliezer Masliah
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

5.  Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.

Authors:  Eliezer Masliah; Edward Rockenstein; Anthony Adame; Michael Alford; Leslie Crews; Makoto Hashimoto; Peter Seubert; Michael Lee; Jason Goldstein; Tamie Chilcote; Dora Games; Dale Schenk
Journal:  Neuron       Date:  2005-06-16       Impact factor: 17.173

6.  The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system.

Authors:  A Iwai; E Masliah; M Yoshimoto; N Ge; L Flanagan; H A de Silva; A Kittel; T Saitoh
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

7.  Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.

Authors:  D W Miller; J M Johnson; S M Solano; Z R Hollingsworth; D G Standaert; A B Young
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

8.  Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein.

Authors:  Deborah E Cabin; Kazuhiro Shimazu; Diane Murphy; Nelson B Cole; Wolfram Gottschalk; Kellie L McIlwain; Bonnie Orrison; Amy Chen; Christopher E Ellis; Richard Paylor; Bai Lu; Robert L Nussbaum
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 9.  Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers.

Authors:  Katrin Beyer
Journal:  Acta Neuropathol       Date:  2006-07-15       Impact factor: 17.088

Review 10.  Oxidative modifications of alpha-synuclein.

Authors:  Harry Ischiropoulos
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

View more
  19 in total

1.  Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy.

Authors:  Elvira Valera; Kiren Ubhi; Michael Mante; Edward Rockenstein; Eliezer Masliah
Journal:  Glia       Date:  2013-12-06       Impact factor: 7.452

2.  Autophagy mediates the clearance of oligodendroglial SNCA/alpha-synuclein and TPPP/p25A in multiple system atrophy models.

Authors:  Panagiota Mavroeidi; Fedra Arvanitaki; Maria Vetsi; Stefan Becker; Dimitrios Vlachakis; Poul Henning Jensen; Leonidas Stefanis; Maria Xilouri
Journal:  Autophagy       Date:  2022-01-09       Impact factor: 13.391

Review 3.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

4.  Familial dementia with frontotemporal features associated with M146V presenilin-1 mutation.

Authors:  Miguel A Riudavets; Leonardo Bartoloni; Juan C Troncoso; Olga Pletnikova; Peter St George-Hyslop; Marcelo Schultz; Gustavo Sevlever; Ricardo F Allegri
Journal:  Brain Pathol       Date:  2013-04-25       Impact factor: 6.508

Review 5.  Multiple system atrophy: pathogenic mechanisms and biomarkers.

Authors:  Kurt A Jellinger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

6.  Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells.

Authors:  Benjamin Ettle; Simone Reiprich; Janina Deusser; Johannes C M Schlachetzki; Wei Xiang; Iryna Prots; Eliezer Masliah; Beate Winner; Michael Wegner; Jürgen Winkler
Journal:  Mol Cell Neurosci       Date:  2014-07-11       Impact factor: 4.314

Review 7.  Multiple system atrophy: experimental models and reality.

Authors:  Cassia Overk; Edward Rockenstein; Elvira Valera; Nadia Stefanova; Gregor Wenning; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2017-10-20       Impact factor: 17.088

8.  Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy.

Authors:  Wolfgang Singer; Allan B Dietz; Anita D Zeller; Tonette L Gehrking; James D Schmelzer; Ann M Schmeichel; Jade A Gehrking; Mariana D Suarez; David M Sletten; Karla V Minota Pacheco; Elizabeth A Coon; Paola Sandroni; Eduardo E Benarroch; Robert D Fealey; Joseph Y Matsumoto; James H Bower; Anhar Hassan; Andrew McKeon; Anthony J Windebank; Jay N Mandrekar; Phillip A Low
Journal:  Neurology       Date:  2019-05-31       Impact factor: 11.800

9.  Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Michael Mante; Harald Weninger; Christina Patrick; Anthony Adame; Sabine Schmidhuber; Radmila Santic; Achim Schneeberger; Walter Schmidt; Frank Mattner; Eliezer Masliah
Journal:  Mol Neurodegener       Date:  2015-03-19       Impact factor: 14.195

Review 10.  Multiple system atrophy: the application of genetics in understanding etiology.

Authors:  Monica Federoff; Lucia V Schottlaender; Henry Houlden; Andrew Singleton
Journal:  Clin Auton Res       Date:  2015-02-17       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.